Endothel Pharma ApS — Credit Rating and Financial Key Figures

CVR number: 37988936
Frederiksgade 19, 1265 København K
sisse.ostrowski@gmail.com

Income statement (kDKK)

2019
2020
2021
2022
2023
Fiscal period length1212121212
Net sales
Gross profit-23.14-12.62-25.13-47.87-57.14
EBIT-23.14-12.62-25.13-47.87-57.14
Other financial expenses-12.97-16.31-21.48-28.39-33.86
Pre-tax profit-36.11-28.93-46.61-76.25-91.00
Net earnings-36.11-28.93-46.61-76.25-91.00

Assets (kDKK)

2019
2020
2021
2022
2023
Development expenditure277.41340.22500.83503.08531.70
Intangible assets total277.41340.22500.83503.08531.70
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables5.000.8241.380.942.48
Short term receivables total5.000.8241.380.942.48
Cash and bank deposits48.9227.460.4950.6524.56
Cash and cash equivalents48.9227.460.4950.6524.56
Balance sheet total (assets)331.33368.50542.71554.67558.74

Equity and liabilities (kDKK)

2019
2020
2021
2022
2023
Share capital75.0075.0075.0075.0075.00
Other reserves277.41340.22500.83503.08531.70
Retained earnings- 367.83- 466.75- 656.29- 705.15- 810.02
Profit of the financial year-36.11-28.93-46.61-76.25-91.00
Shareholders equity total-51.53-80.46- 127.07- 203.32- 294.32
Non-current liabilities total
Current trade creditors13.0013.2313.4213.7915.96
Other non-interest bearing current liabilities369.87435.72656.36744.20837.11
Current liabilities total382.87448.96669.78757.99853.06
Balance sheet total (liabilities)331.33368.50542.71554.67558.74
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.